President Trump orders cheaper drug prices, setting global price targets, amid concerns it could harm innovation.

President Trump issued an executive order to reduce prescription drug prices in the U.S., directing the Secretary of Health and Human Services to set "most-favored-nation" price targets for drugs. This would require pharmaceutical companies to offer medications to Americans at their lowest global prices. Critics argue this could lead to higher drug costs overseas and reduced drug company profits, potentially harming innovation. The order aims to address high drug prices in the U.S. but has faced backlash as an overreach into market control.